The US Food and Drug Administration kept up a blistering pace of new drug approvals last year, all while navigating the urgent evaluation of tests, drugs, and vaccines in development for COVID-19. The ...

SOURCE Authors’ analysis of Medicare Part D Drug Spending Dashboard & Data, 2012–18. NOTES The share of Medicare Part D spending on drugs in each cost category was calculated based on total Medicare ...

Specialty drugs now account for more than half of pharmacy spend, a new report from CVS Health shows. CVS Caremark released its annual Drug Trend Report, which found that specialty medications ...

In 2012, Lynn Scarfuto was diagnosed with chronic lymphocytic leukemia. After surgeries and rounds of chemotherapy, her oncologist prescribed the oral medication Imbruvica, a drug that costs more than ...

There is no sole Medicare drug price list currently available, as medication costs and availability can vary according to the company administering a Part D prescription drug plan. A person must ...

Aayan N. Patel is a researcher in the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ...

A year into the COVID-19 pandemic, the first authorized drugs and vaccines indicated for the virus have generated more than a combined $4.23 billion for their developers, according to sales figures ...

As COVID-19 cases surge around the world because of the highly contagious Omicron variant, doctors are hoping that Paxlovid, Pfizer’s oral COVID-19 treatment, could be a lifeline for some. Although it ...

Drug shortages are a clear and growing challenge. Prominent shortages included oncology medications and supportive care products essential for the care of patients with cancer. Oncology drug shortages ...